RE: A couple of observations21 Nov 2022 17:34
Hi Glen
Couple of points
I called it red very early so of course there was little volume
The rns was about a peer review of about sra737 which gsk decided not to continue with so currently has little commercial value
The rns was not what people expected as we all know there is more important news to come out
Stop thinking the board is riddled with people trying to bring price down. Saying it would fall to 50p and wanting it to fall are 2 different things
Only when we get an rns about 1801 will know what's going on
Lastly as a holder I would think you want it to slide so you can buy more. I personally think all holders want it to slide as tbh the price of 20 to 30 quid is years off so why not let it slide, buy cheap and sit on it for a few years? Who cares if it gets back to 2 quid, you guys still would not sell anyway. Dropping to 50p is in your interest if you truly believe in sar